Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy

Frank I. Lin, E. M. Gonzalez, S. Kummar, K. Do, J. Shih, S. Adler, K. A. Kurdziel, A. Ton, B. Turkbey, P. M. Jacobs, S. Bhattacharyya, A. P. Chen, J. M. Collins, J. H. Doroshow, P. L. Choyke, M. L. Lindenberg

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences